Patents by Inventor Rainer Oberbauer

Rainer Oberbauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING LEFT VENTRICLE HYPERTROPHY
    Publication number: 20230201313
    Abstract: Disclosed are methods for treatment of a subject with left ventricle hypertrophy. Also disclosed are methods for slowing or delaying progression of left ventricle hypertrophy, as well as methods for mediating cardiac remodeling and for improving cardiac function in subjects with left ventricle hypertrophy. The methods comprise administering etelcalcetide parenterally to a subject.
    Type: Application
    Filed: May 14, 2021
    Publication date: June 29, 2023
    Inventors: Rainer OBERBAUER, Bruno FOUQUERAY, Katharina DÖRR
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20170016070
    Abstract: The present invention relates to a method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: July 25, 2016
    Publication date: January 19, 2017
    Inventor: Rainer Oberbauer
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20140303024
    Abstract: The present invention relates to a method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: June 3, 2014
    Publication date: October 9, 2014
    Inventor: Rainer Oberbauer
  • Acute kidney injury risk testing
    Patent number: 8728984
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of one or more marker(s) selected from REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG or any combination thereof in a sample.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: May 20, 2014
    Inventors: Rainer Oberbauer, Julia Wilflingseder, Bernd Mayer, Paul Perco, Alexander Kainz
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20130172205
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: December 4, 2012
    Publication date: July 4, 2013
    Inventors: Rainer Oberbauer, Bernd Mayer, Paul Perco, Alexander Kainz
  • Markers of acute kidney failure
    Patent number: 8338096
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: December 25, 2012
    Inventors: Rainer Oberbauer, Alexander Kainz, Bernd Mayer, Paul Perco
  • ACUTE KIDNEY INJURY RISK TESTING
    Publication number: 20120202705
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of one or more marker(s) selected from REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG or any combination thereof in a sample.
    Type: Application
    Filed: October 8, 2010
    Publication date: August 9, 2012
    Inventors: Rainer Oberbauer, Julia Wilflingseder, Bernd Mayer, Paul Perco, Alexander Kainz
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20110059857
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: April 15, 2009
    Publication date: March 10, 2011
    Inventors: Rainer Oberbauer, Bernd Mayer, Paul Perco, Alexander Kainz
  • Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide
    Patent number: 5840875
    Abstract: This invention is a method for treating diseases involving the mammalian kidney proximal tubule epithelium with naked antisense oligonucleotides and antisense compositions against the mRNA of mammalian kidney epithelial proteins.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 24, 1998
    Assignee: C.V. Therapeutics
    Inventors: George F. Schreiner, Timothy W. Meyer, Rainer Oberbauer